VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $94,747 | -58.6% | 12,821 | -44.6% | 0.00% | -66.7% |
| Q3 2022 | $229,000 | -72.4% | 23,155 | -69.6% | 0.00% | -66.7% |
| Q2 2022 | $829,000 | -69.4% | 76,063 | -68.3% | 0.01% | -60.9% |
| Q1 2022 | $2,710,000 | +43.6% | 239,627 | +99.2% | 0.02% | +64.3% |
| Q4 2021 | $1,887,000 | -12.2% | 120,298 | -4.1% | 0.01% | -12.5% |
| Q3 2021 | $2,150,000 | -25.1% | 125,417 | -6.0% | 0.02% | -20.0% |
| Q2 2021 | $2,870,000 | +39.7% | 133,411 | -2.4% | 0.02% | +42.9% |
| Q1 2021 | $2,054,000 | +17.2% | 136,758 | +2.5% | 0.01% | 0.0% |
| Q4 2020 | $1,753,000 | +160.9% | 133,389 | +91.8% | 0.01% | +100.0% |
| Q3 2020 | $672,000 | +71.9% | 69,548 | +103.3% | 0.01% | +75.0% |
| Q2 2020 | $391,000 | +33.4% | 34,206 | +20.9% | 0.00% | 0.0% |
| Q1 2020 | $293,000 | -35.0% | 28,287 | +2.9% | 0.00% | 0.0% |
| Q4 2019 | $451,000 | +137.4% | 27,479 | +92.3% | 0.00% | +100.0% |
| Q3 2019 | $190,000 | – | 14,286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |